MA23651A1 - Spirostanylglycosides cristallins, procede pour leur preparation et compositions les contenant - Google Patents

Spirostanylglycosides cristallins, procede pour leur preparation et compositions les contenant

Info

Publication number
MA23651A1
MA23651A1 MA23993A MA23993A MA23651A1 MA 23651 A1 MA23651 A1 MA 23651A1 MA 23993 A MA23993 A MA 23993A MA 23993 A MA23993 A MA 23993A MA 23651 A1 MA23651 A1 MA 23651A1
Authority
MA
Morocco
Prior art keywords
spirostanylglycosides
crystalline
preparation
compositions containing
compositions
Prior art date
Application number
MA23993A
Other languages
English (en)
Inventor
A Bouzon Richard
P Deninno Michael
B Zung Jonathan
J M Allen Douglas
A Watson Harry
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of MA23651A1 publication Critical patent/MA23651A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
MA23993A 1994-08-30 1995-08-21 Spirostanylglycosides cristallins, procede pour leur preparation et compositions les contenant MA23651A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US29810694A 1994-08-30 1994-08-30

Publications (1)

Publication Number Publication Date
MA23651A1 true MA23651A1 (fr) 1996-04-01

Family

ID=23149057

Family Applications (1)

Application Number Title Priority Date Filing Date
MA23993A MA23651A1 (fr) 1994-08-30 1995-08-21 Spirostanylglycosides cristallins, procede pour leur preparation et compositions les contenant

Country Status (20)

Country Link
US (1) US5804562A (fr)
EP (1) EP0778846A1 (fr)
JP (1) JPH09510735A (fr)
KR (1) KR970705574A (fr)
AU (1) AU2265395A (fr)
BR (1) BR9503827A (fr)
CA (1) CA2198097A1 (fr)
CO (1) CO4480032A1 (fr)
FI (1) FI970828A0 (fr)
HR (1) HRP950459A2 (fr)
IL (1) IL115062A0 (fr)
MA (1) MA23651A1 (fr)
MX (1) MX9701525A (fr)
NO (1) NO970910D0 (fr)
OA (1) OA10402A (fr)
PE (1) PE47696A1 (fr)
PL (1) PL318937A1 (fr)
SI (1) SI9520092A (fr)
TR (1) TR199501065A2 (fr)
WO (1) WO1996006854A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3768100B2 (ja) * 1998-03-26 2006-04-19 ファイトファーム・ピーエルシー アルツハイマー病を治療するためのステロイドサポゲニンとその誘導体
GB9923076D0 (en) * 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
GB9923078D0 (en) * 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
GB9923077D0 (en) * 1999-09-29 1999-12-01 Phytopharm Plc Sapogenin derivatives and their use
GB0000228D0 (en) * 2000-01-06 2000-03-01 Phytopharm Plc Fluoro substituted sapogenins and their use
GB0107822D0 (en) * 2001-03-28 2001-05-23 Phytopharm Plc Sapogenin derivatives their synthesis and use methods based upon their use
CN102727501A (zh) * 2002-03-27 2012-10-17 菲特法姆股份有限公司 皂角苷配基及其衍生物的用途
US20050130948A1 (en) * 2002-03-27 2005-06-16 Daryl Rees Therapeutic methods and uses of sapogenins and their derivatives

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK158394A3 (en) * 1992-06-26 1995-05-10 Pfizer Steroidal glycosides
WO1995018144A1 (fr) * 1993-12-28 1995-07-06 Pfizer Inc. Glycosides steroidiens

Also Published As

Publication number Publication date
SI9520092A (en) 1997-12-31
US5804562A (en) 1998-09-08
FI970828A (fi) 1997-02-27
IL115062A0 (en) 1995-12-08
NO970910L (no) 1997-02-27
FI970828A0 (fi) 1997-02-27
JPH09510735A (ja) 1997-10-28
OA10402A (en) 2001-12-05
WO1996006854A1 (fr) 1996-03-07
AU2265395A (en) 1996-03-22
CA2198097A1 (fr) 1996-03-07
HRP950459A2 (en) 1997-08-31
KR970705574A (ko) 1997-10-09
MX9701525A (es) 1997-05-31
NO970910D0 (no) 1997-02-27
EP0778846A1 (fr) 1997-06-18
BR9503827A (pt) 1996-09-10
CO4480032A1 (es) 1997-07-09
TR199501065A2 (tr) 1996-06-21
PE47696A1 (es) 1996-11-12
PL318937A1 (en) 1997-07-21

Similar Documents

Publication Publication Date Title
MA23866A1 (fr) N-(indole-2-carbonyl)-glycinamides substitues, procede pour leur preparation et compositions les contenant
MA26687A1 (fr) 4-carboxyamino-2-methyl-1,2,3,4-tetrahydroquinoleines, procede pour leur preparation et compositions pharmaceutiques les contenant
MA22521A1 (fr) Compositions anti- transpirantes en batonnets-gels contenant un derive de la 2-oxazolidinone, et procede pour leur preparation
MA23831A1 (fr) Derives de quinazoline, procede pour leur preparation et composition les contenant
MA23880A1 (fr) Amines bicycliques utiles comme insecticides, procede pour leur preparation et compositions les contenant
FR2780057B1 (fr) Phenoxypropanolamines, procede pour leur preparation et compositions pharmaceutiques les contenant
MA24832A1 (fr) Hydroxamides d'acides (4-arylsulfonylamino)-tetrahydropyranne-4-carboxyliques), procede pour leur preparation et compositions les contenant
MA24469A1 (fr) Derives d'acide arylsulfonyhydroxamique, procede pour leur preparation et compositions les contenant
MA24529A1 (fr) Pyrazolopyrimidinones nouvelles, procede pour leur preparation et compositions les contenant .
MA26630A1 (fr) 4-phenylpyperidines nouvelles, procede pour leur preparation et compositions pharmaceutiques les contenant
MA24158A1 (fr) Derives d'imidazole substitues, procede pour leur preparation et compositions les contenant
MA26415A1 (fr) Composes heterocycliques, procede pour la preparation et compositions pharmaceutiques les contenant
MA26451A1 (fr) Amides inhibiteurs de secretion de apo b/mtp, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26654A1 (fr) Pyrrolopyrimidines nouvelles procede pour leur preparation et compositions pharmaceutiques les contenant
FR2665453B1 (fr) Polylactides purifies, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26433A1 (fr) Derives de pyridylpyrrole, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2729951B1 (fr) Nouveaux composes heterocycliques, procede pour leur preparation et compositions pharmaceutiques en contenant
MA26686A1 (fr) Derives de 4,4-biarylpiperidine nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
DZ2045A1 (fr) Amides thérapeutiques, procédé pour leur préparation et compositions les contenant.
MA26438A1 (fr) Derives 6,5-heterobicycliques substitues, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA24414A1 (fr) Derives de pyrazole parasiticides, procede pour leur preparation et composition les contenant
MA26559A1 (fr) Derives de d-proline, procede pour leur preparation, compositions pharmaceutiques les contenant et leur utilisation
MA26425A1 (fr) Derives de lactames, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2751334B1 (fr) Polysaccharides synthetiques, procede pour leur preparation et compositions pharmaceutiques les contenant
MA26417A1 (fr) Azetidines, procede pour leur preparation, et compositions pharmaceutiques les contenant